PHARMACEUTICALS TREATING ALZHEIMER S DISEASE

Brand Owner Address Description
NEUEXCELL NeuExcell Therapeutics Inc. Suite 242 401 N. Broad St. Philadelphia PA 19108 Pharmaceuticals for treating Alzheimer's Disease, Parkinson's Disease, amyotrophic lateral sclerosis (ALS), Huntington's Disease, epilepsy, spinal cord injury, stroke, cerebral aneurysm, traumatic brain injury, concussion, a tumor, cancer, inflammation, viral and baterial infections, ataxia, brain atrophy, spinal cord atrophy, multiple sclerosis, traumatic spinal cord injury, ischemic or hemorrhagic myelopathy (myelopathy), global ischemia, hypoxic ischemic encephalopathy, embolism, fibrocartilage embolism myelopathy, thrombosis, nephropathy, chronic inflammatory disease, meningitis, and cerebral venous sinus thrombosis;NEURO EXCEL;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The invention relates to a method of treating Alzheimer's disease in a mammal comprising administering to the mammal an anti-microbial agent having anti-Chlamydia pneumoniae activity. The invention also relates to a method of diagnosing Alzheimer's disease in a mammal comprising measuring the serum anti-Chlamydia pneumoniae antibody titer in a patient suspected of having Alzheimer's disease.